Journal article icon

Journal article

Effect of central nervous system metastases on treatment discontinuation and survival in older women receiving trastuzumab for metastatic breast cancer.

Abstract:

Background. Trastuzumab improves survival in HER2-positive women with metastatic breast cancer (MBC). The consequences of longer survival include a higher likelihood of additional metastases, including those in the central nervous system (CNS). The effect of CNS metastases on both trastuzumab discontinuation and survival in older patients has not been described. Patients and Methods. We used the Surveillance Epidemiology and End Results (SEER) Medicare data to identify a cohort of 562 women a...

Expand abstract

Actions


Access Document


Publisher copy:
10.1155/2012/819210

Authors


Danese, MD More by this author
Lindquist, K More by this author
Brammer, M More by this author
Expand authors...
Journal:
Journal of cancer epidemiology
Volume:
2012
Pages:
819210
Publication date:
2012
DOI:
EISSN:
1687-8566
ISSN:
1687-8558
URN:
uuid:1442b158-8cf2-4e6d-bd75-401c9724f156
Source identifiers:
359094
Local pid:
pubs:359094
Language:
English

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP